Logo
Logo

About Glimepiride API

Product
  • Therapeutic CategoryAnti-Diabetic

  • CAS Number

    93479-97-1

  • API Technology

    Synthetic

  • Dose Form

    Oral Solid/Tablets

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, CEP Submitted

Mechanism of Action

Glimepiride primarily lowers blood glucose by stimulating the release of insulin from pancreatic beta cells. Sulfonylureas bind to the sulfonylurea receptor in the pancreatic beta-cell plasma membrane, leading to closure of the ATP-sensitive potassium channel, thereby stimulating the release of insulin.

Indication

AMARYL is a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Important Limitations of Use:

  • Not for treating type 1 diabetes mellitus or diabetic ketoacidosis

Related APIs

Dapagliflozin (PG Solvate Monohydrate)

Anti-Diabetic

arrow

Glimepiride

Anti-Diabetic

arrow

Linagliptin

Anti-Diabetic

arrow

Liraglutide

Anti-Diabetic

arrow

Pioglitazone Hydrochloride

Anti-Diabetic

arrow

Sitagliptin Hydrochloride

Anti-Diabetic

arrow

Dapagliflozin (Amorphous)

Anti-Diabetic

arrow

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone

FAQs

What is Glimepiride API used for?
  • Glimepiride is used to treat type 2 diabetes by improving glycemic control.

What are the benefits of Glimepiride API?
  • Lowers blood sugar, reduces risk of diabetes complications, and can be used with other diabetes medications.

What are the recommended dosages for Glimepiride?
  • Start with 1-2 mg daily, max 8 mg per day.

How do you store Glimepiride API?
  • Store at room temperature, 20°C to 25°C

Disclaimer

No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.